Wedbush Securities Inc Liquidia Corp Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $26,520 - $59,058	-10,200 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$4.34 - $8.28 $44,268 - $84,456	10,200 New	10,200 $50,000
Q1 2020 Apr 17, 2020	SELL	$3.31 - $7.15 $46,009 - $99,385	-13,900 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$3.07 - $5.11 $42,673 - $71,029	13,900 New	13,900 $59,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.